scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM101052G |
P698 | PubMed publication ID | 21207958 |
P50 | author | Peter Brandt | Q57030030 |
P2093 | author name string | Matthis Geitmann | |
U Helena Danielson | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 709-718 | |
P577 | publication date | 2011-01-05 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments | |
P478 | volume | 54 |
Q27675974 | Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening |
Q26826945 | Fragment screening and HIV therapeutics |
Q38211688 | Harnessing allostery: a novel approach to drug discovery |
Q35616254 | Ligand deconstruction: Why some fragment binding positions are conserved and others are not |
Q49330155 | Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA. |
Q41109181 | Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors. |
Search more.